WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported a loss of $653,000 in its third quarter. On a per-share basis, the Waltham, Massachusetts-based company said it ...

WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a ...

WALTHAM, Mass., November 12, 2024--(BUSINESS WIRE)--Dynatrace (NYSE: DT) today announced that its executives will present at ...

Repligen Corporation, established in 1981 and headquartered in Waltham, Massachusetts, is a global life sciences company ...

Third quarter reported revenue of $155 million, an increase of 10% year-over-yearCDMO revenue and orders both up ~20% year-over-yearOverall order ...

A lottery player won $50,000 playing Powerball in Massachusetts on Monday. The winning numbers for the Powerball drawing on ...

Repligen sees FY24 adjusted EPS $1.50-$1.58, consensus $1.43 Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

For its fans, any episode of Friends is a guaranteed laugh – or at least a guaranteed smile. So it’s hard to imagine it being ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

WALTHAM, Mass. and BOULDER, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...

WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical ...